Filtros : "QUEIROZ, ROSANE GOMES DE PAULA" "São Paulo Medical Journal" Removido: "FÁRMACOS" Limpar

Filtros



Refine with date range


  • Source: São Paulo Medical Journal. Unidade: FMRP

    Subjects: NEOPLASIAS, CÉREBRO, POLIMORFISMO (GENÉTICA)

    Versão PublicadaAcesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VALENTIN, Mev Dominguez et al. Frequency of polymorphisms and protein expression of cyclin-dependent kinase inhibitor 1A (CDKN1A) in central nervous system tumors. São Paulo Medical Journal, v. 127, n. 5, p. 288-294, 2009Tradução . . Disponível em: https://doi.org/10.1590/s1516-31802009000500008. Acesso em: 01 out. 2024.
    • APA

      Valentin, M. D., Canalle, R., Queiroz, R. G. de P., & Tone, L. G. (2009). Frequency of polymorphisms and protein expression of cyclin-dependent kinase inhibitor 1A (CDKN1A) in central nervous system tumors. São Paulo Medical Journal, 127( 5), 288-294. doi:10.1590/s1516-31802009000500008
    • NLM

      Valentin MD, Canalle R, Queiroz RG de P, Tone LG. Frequency of polymorphisms and protein expression of cyclin-dependent kinase inhibitor 1A (CDKN1A) in central nervous system tumors [Internet]. São Paulo Medical Journal. 2009 ; 127( 5): 288-294.[citado 2024 out. 01 ] Available from: https://doi.org/10.1590/s1516-31802009000500008
    • Vancouver

      Valentin MD, Canalle R, Queiroz RG de P, Tone LG. Frequency of polymorphisms and protein expression of cyclin-dependent kinase inhibitor 1A (CDKN1A) in central nervous system tumors [Internet]. São Paulo Medical Journal. 2009 ; 127( 5): 288-294.[citado 2024 out. 01 ] Available from: https://doi.org/10.1590/s1516-31802009000500008
  • Source: São Paulo Medical Journal. Unidade: FMRP

    Subjects: ONCOLOGIA, PEDIATRIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VALERA, Elvis Terci et al. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia. São Paulo Medical Journal, v. 122, n. 4, p. 166-171, 2004Tradução . . Disponível em: https://doi.org/10.1590/s1516-31802004000400007. Acesso em: 01 out. 2024.
    • APA

      Valera, E. T., Scrideli, C. A., Queiroz, R. G. de P., & Tone, L. G. (2004). Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia. São Paulo Medical Journal, 122( 4), 166-171. doi:10.1590/s1516-31802004000400007
    • NLM

      Valera ET, Scrideli CA, Queiroz RG de P, Tone LG. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia [Internet]. São Paulo Medical Journal. 2004 ; 122( 4): 166-171.[citado 2024 out. 01 ] Available from: https://doi.org/10.1590/s1516-31802004000400007
    • Vancouver

      Valera ET, Scrideli CA, Queiroz RG de P, Tone LG. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia [Internet]. São Paulo Medical Journal. 2004 ; 122( 4): 166-171.[citado 2024 out. 01 ] Available from: https://doi.org/10.1590/s1516-31802004000400007

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024